Exchange: NASDAQ·Updated 05:53 AM EDT

VACC Vaccitech plc - ADR

$0.83
$0.087
(11.71%)
Pre-Market
Prev Close $0.743
Reported EarningsAug 6
Mkt Cap$30.35M
Vol4,107.00

About VACC

Barinthus Biotherapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer. It also focuses on the pipeline of both clinical and preclinical stage therapeutic, and prophylactic programs. The company was founded by Adrian Hill and Dame Sarah Gilbert in March 2021 and is headquartered in Didcot, the United Kingdom.
50

Neutral Sentiment

How do you feel about VACC?

Advertisement|Remove ads.